Current Valuation
N/A
As of December 17, 2024
Total Funding Raised
$28.8M
Last Round
Later Stage VC

Amount undisclosed

Last Funding
Dec 2024

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Great Bay Bio is currently valued at N/A as of December 17, 2024. The company has raised a total of $28.8M in funding.

Investment Perspective

Great Bay Bio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Great Bay Bio Valuation Updates

Get notified when Great Bay Bio raises new funding or valuation changes

What is Great Bay Bio Worth in 2025?

As of 2025, Great Bay Bio is valued at N/A, based on the company's Later Stage VC funding round in December 17, 2024. This valuation positions Great Bay Bio as one of the leading private companies in the sector.

Great Bay Bio Valuation History

Great Bay Bio's funding history demonstrates steady growth and investor confidence.

How Great Bay Bio Valuation is Determined

Private company valuations like Great Bay Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Great Bay Bio Valuation FAQs

Is Great Bay Bio profitable?

Great Bay Bio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Great Bay Bio's valuation compare to competitors?

Great Bay Bio is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Great Bay Bio IPO?

Great Bay Bio has not announced plans for an initial public offering. Until an IPO, investors can access Great Bay Bio shares through secondary market platforms.